Publications (34) AMAIA MAITE ERDOZAIN FERNANDEZ publications

2024

  1. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

  2. In need of a specific antibody against the oxytocin receptor for neuropsychiatric research: A KO validation study

    Journal of Psychiatric Research, Vol. 173, pp. 260-270

2023

  1. Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 348-365

  2. The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder

    Biomolecules, Vol. 13, Núm. 2

2021

  1. Characterization of Hevin (SPARCL1) Immunoreactivity in Postmortem Human Brain Homogenates

    Neuroscience, Vol. 467, pp. 91-109

  2. Europar Batasunean merkaturatutako SARS-CoV-2 birusaren aurkako txertoen onura/arrisku orekaren ebaluazioa

    Osagaiz: osasun-zientzien aldizkaria, Vol. 5, Núm. 2, pp. 77-96

  3. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  4. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2020

  1. G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism

    Frontiers in Cellular Neuroscience, Vol. 14

  2. Oxytocin as Treatment for Social Cognition, Not There Yet

    Frontiers in Psychiatry, Vol. 10

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons

    Brain Structure and Function, Vol. 224, Núm. 3, pp. 1219-1244

2018

  1. Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 81, pp. 236-242

  2. Sinapsien ikuspegi modernoa: zelulaz kanpoko matrizearen funtzioa konexio neuronalean

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 34, pp. 41-57

  3. Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions

    Neuropsychopharmacology, Vol. 43, Núm. 5, pp. 1041-1051

  4. The loss of α-and β-tubulin proteins are a pathological hallmark of chronic alcohol consumption and natural brain ageing

    Brain Sciences, Vol. 8, Núm. 9

2017

  1. Ama-esnea, gizadiaren bermea

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 32, pp. 179-189

  2. Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I2 Receptor Ligands

    ACS Chemical Neuroscience, Vol. 8, Núm. 4, pp. 737-742

2015

  1. Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects

    Journal of Psychopharmacology, Vol. 29, Núm. 11, pp. 1137-1145

  2. Ctr9, a protein in the transcription complex Paf1, regulates dopamine transporter activity at the plasma membrane

    Journal of Biological Chemistry, Vol. 290, Núm. 29, pp. 17848-17862